{
    "name": "SQ1: XALIPRODEN-Amyotrophic Lateral Sclerosis COP(P)",
    "natural": "Clinical Outcome Pathway (phenotype)",
    "notes": "SQ1",
    "machine_question": [
        {
            "nodeSpecType": "Named Node",
            "type": "chemical_substance",
            "label": "XALIPRODEN",
            "meta": {
                "identifier": "MESH:C462299"
            }
        },
        {
            "nodeSpecType": "Node Type",
            "type": "gene",
            "label": "gene",
            "meta": {}
        },
        {
            "nodeSpecType": "Node Type",
            "type": "biological_process_or_molecular_activity",
            "label": "biological_process_or_molecular_activity",
            "meta": {}
        },
        {
            "nodeSpecType": "Node Type",
            "type": "cell",
            "label": "cell",
            "meta": {}
        },
        {
            "nodeSpecType": "Node Type",
            "type": "anatomical_entity",
            "label": "anatomical_entity",
            "meta": {}
        },
        {
            "nodeSpecType": "Named Node",
            "type": "phenotypic_feature",
            "label": "Amyotrophic Lateral Sclerosis",
            "meta": {
                "identifier": "HP:0007354"
            }
        }
    ]
}